TENON MEDICAL, INC.

TNON

CIK 0001560293 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1M
↑+92.3% +$711Kvs FY2024 (Q4)
Operating Income
$395K
Net Income
$395K
Gross Profit
$1M
↑+188.1% +$664Kvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Weak
32/100
  • Profitability
    0ROIC -183.6% (10% = solid, 20%+ = moat)
  • Liquidity
    80Current Ratio 2.11 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    14Asset Turnover 0.38x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +92.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Op Margin -289.2% · trend -7.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$192K
investment in PP&E
Stock-based comp (TTM)
$2M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$11M
everything owned
Total liabilities
$6M
everything owed
Stockholders' equity
$5M
shareholder claim

Recent performance · 20 quarters

Revenue↑+92.3% +$711K
$1M
Net Income↓-4.9% -$155K
$-3M
Free Cash Flow
$-192K
Operating Margin↑+73.3pts
-289.2%

Drill down